About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

310. Congenital anomalies syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 12 / Drugs : 16 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 8

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Antioxidants
   University of Colorado, Denver
      2008   Phase 2   NCT01773278   United States
Cholesterol
   University of Colorado, Denver
      2008   Phase 2   NCT01773278   United States
Cholesterol supplementation
   Oregon Health and Science University
      2011   -   NCT01356420   United States
Cholesterol suspension
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1998   -   NCT00001721   United States
Cholic acid
   University of Nebraska
      2021   Phase 1/Phase 2   NCT03720990   United States
CRH
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      1998   -   NCT00001721   United States
Crystalline cholesterol OIL-based suspension
   Boston Children’s Hospital
      1998   Phase 1/Phase 2   NCT00272844   United States
DHC
   Obstetrics and Gynecology Hospital Affiliated to Fudan University
      2020   Phase 0   ChiCTR2000035477   China
EGG substitute, without cholesterol
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2005   Phase 2   NCT00114634   United States
EGG yolk preparation with cholesterol
   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
      2005   Phase 2   NCT00114634   United States
Lactose
   Oregon Health and Science University
      2011   -   NCT01434745   United States
Lithium carbonate capsule
   University of Milan
      2024   Phase 2/Phase 3   NCT06789783   Italy
Lovastatin
   Northwestern University
      2011   Phase 2   NCT01110642   United States
N-acetyl cysteine
   Johns Hopkins University
      2025   Phase 2   NCT04381897   United States
Oraplus
   Forbes Porter, M.D.
      2003   Phase 2   NCT00064792   United States
Simvastatin
   Forbes Porter, M.D.
      2003   Phase 2   NCT00064792   United States
   Oregon Health and Science University
      2011   -   NCT01434745   United States